Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, August 14, 2012, to discuss the second-quarter 2012 financial results and recent business activities. The conference call may be accessed by calling:
United States: | 1-866-519-4004 |
China (Landline): | 800-819-0121 |
China (Mobile): | 400-620-8038 |
Hong Kong: | 800-930-346 |
United Kingdom: | 0-808-234-6646 |
International: | +65-6723-9381 |
Conference ID: | 10406942 |
A telephone replay will be available two hours after the call's completion at:
United States: | 1-866-214-5335 |
China North: | 10-800-714-0386 |
China South: | 10-800-140-0386 |
Hong Kong: | 800-901-596 |
United Kingdom: | 0-800-731-7846 |
International: | +61-2-8235-5000 |
Conference ID: | 10406942 |
A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com/.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
For more information, please contact:
Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com
SOURCE WuXi PharmaTech (Cayman) Inc.
